Camelot Portfolios, LLC Baxter International Inc Transaction History

Camelot Portfolios, LLC

$167 Million
Q3 2025

A detailed history of Camelot Portfolios, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Camelot Portfolios, LLC holds 40,611 shares of BAX stock, worth $750,085. This represents 0.55% of its overall portfolio holdings.

Number of Shares

40,611

Previous 40,809 0.49%

Holding current value

$750,085

Previous $1.24 Million 25.18%

% of portfolio

0.55%

Previous 0.76%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 17, 2025	SELL	$21.71 - $31.23 $4,298 - $6,183	-198 Reduced 0.49%	40,611 $924,000
Q2 2025 Jul 17, 2025	SELL	$27.8 - $34.02 $26,493 - $32,421	-953 Reduced 2.28%	40,809 $1.24 Million
Q1 2025 May 13, 2025	BUY	$29.26 - $36.57 $440,245 - $550,232	15,046 Added 56.32%	41,762 $1.43 Million
Q4 2024 Feb 03, 2025	SELL	$28.63 - $37.84 $34,470 - $45,559	-1,204 Reduced 4.31%	26,716 $779,000
Q3 2024 Nov 12, 2024	SELL	$32.85 - $40.26 $355,929 - $436,217	-10,835 Reduced 27.96%	27,920 $1.06 Million

Q2 2024 Aug 12, 2024	BUY	$32.87 - $43.55 $366,730 - $485,887	11,157 Added 40.43%	38,755 $1.3 Million
Q1 2024 May 08, 2024	SELL	$37.88 - $43.77 $472,363 - $545,811	-12,470 Reduced 31.12%	27,598 $1.18 Million
Q4 2023 Jan 23, 2024	BUY	$31.71 - $38.95 $348,746 - $428,372	10,998 Added 37.83%	40,068 $1.55 Million
Q3 2023 Oct 20, 2023	SELL	$37.32 - $49.29 $240,863 - $318,117	-6,454 Reduced 18.17%	29,070 $1.1 Million
Q2 2023 Jul 25, 2023	SELL	$39.98 - $47.68 $39,620 - $47,250	-991 Reduced 2.71%	35,524 $1.62 Million
Q1 2023 Apr 20, 2023	BUY	$37.58 - $52.57 $1.37 Million - $1.92 Million	36,515 New	36,515 $1.48 Million

Others Institutions Holding BAX

# of Institutions

886

Shares Held

480M

Call Options Held

2.25M

Put Options Held

3.56M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $9.31B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camelot Portfolios, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camelot Portfolios, LLC with notifications on news.

Account

Camelot Portfolios, LLC Baxter International Inc Transaction History